featured
Safety and Immunogenicity of mRNA Vaccines Against SARS-CoV-2 in Patients With Lung Cancer Receiving Immune Checkpoint Inhibitors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Thoracic Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Safety and Immunogenicity of mRNA Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Lung Cancer Receiving Immune Checkpoint Inhibitors: A Multicenter Observational Study in Japan
J Thorac Oncol 2022 Jun 22;[EPub Ahead of Print], M Hibino, K Uryu, T Takeda, Y Kunimatsu, S Shiotsu, J Uchino, S Hirai, T Yamada, A Okada, Y Hasegawa, O Hiranuma, Y Chihara, R Kamada, S Tobe, K Maeda, S Horiuchi, T Kondo, K TakayamaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.